HYPERTENSION, PULMONARY
Clinical trials for HYPERTENSION, PULMONARY explained in plain language.
Never miss a new study
Get alerted when new HYPERTENSION, PULMONARY trials appear
Sign up with your email to follow new studies for HYPERTENSION, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Heart-Lung drug help kids with pulmonary hypertension?
Disease control OngoingThis study tests a drug called riociguat in children aged 6 to 18 who have pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes it hard to breathe and move. The goal is to see if the drug is safe and how the body processes it at differen…
Matched conditions: HYPERTENSION, PULMONARY
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
Heart-Lung hope: new drug sotatercept tested for tough hypertension
Disease control OngoingThis study looks at the long-term safety of a drug called sotatercept for people with a specific type of pulmonary hypertension caused by heart failure with preserved ejection fraction. About 130 people who completed a prior study will receive sotatercept injections and be monito…
Matched conditions: HYPERTENSION, PULMONARY
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could this pill help kids with rare lung disease?
Disease control OngoingThis study tests whether adding selexipag to standard treatment can delay disease worsening in children aged 2 to 18 with pulmonary arterial hypertension (PAH). About 138 children will receive either selexipag or a placebo, plus their usual medications. The main goal is to see if…
Matched conditions: HYPERTENSION, PULMONARY
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for PAH patients: Long-Term drug safety trial opens
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of the drug ralinepag in people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. About 1,000 adults who were in earlier ralinepag studies can join. The goal is to see if the drug remains s…
Matched conditions: HYPERTENSION, PULMONARY
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC